Product image of Eribulin Medac (Eribulin) supplied by GNH India

Eribulin Medac

Active Ingredient:
Eribulin
Origin:
EU

Eribulin Medac (Eribulin)

Eribulin Medac is a medication used in cancer treatment, specifically for certain types of advanced breast cancer. This intravenous drug is designed to target and destroy cancer cells, offering a therapeutic option for patients.

Manufacturer / TM Owner

Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Eribulin Medac is primarily used in the treatment of metastatic breast cancer. It is often prescribed for patients who have previously undergone other cancer treatments without success. The drug works by interfering with the cell division process, which can help slow the growth and spread of cancer cells. Patients and healthcare providers may discuss what is Eribulin used for in more detail during consultations.

Side Effects

  • Common effects of Eribulin Medac may include fatigue, nausea, and hair loss. Some patients might experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. These effects can vary from person to person, and it's important to monitor any changes and discuss them with a healthcare professional.

Precautions & Warnings

  • Eribulin Medac should be handled with care, as it is intended for intravenous use only. It is crucial to follow the administration guidelines provided by healthcare professionals to ensure safe and effective use. Patients should be aware of potential side effects and report any severe or persistent symptoms to their healthcare provider immediately.

Avoid Interactions

  • Eribulin Medac may interact with other medications, including those that affect the liver or bone marrow. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements might also interact with Eribulin, so patients should discuss their full medical history and current treatments with their healthcare team.

Frequently Asked Questions

Eribulin Medac is used in the treatment of metastatic breast cancer, particularly in patients who have not responded to other treatments.

Eribulin Medac is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, hair loss, and peripheral neuropathy.

Patients should consult their healthcare provider about potential interactions with other medications before taking Eribulin Medac.

If severe side effects occur, patients should contact their healthcare provider immediately for guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eribulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT